|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Distribution of myoglobin in mice induce multiple compensatory mechanism显示文摘 | Godecke A Flogel U Zanger K | 1999 | Proc Natl Acad Sci USA1999，96，10： | 1 |
| 2 | Frequency of C3435T polymorphism of MDR1 gene in African people显示文摘 | Schaeffeler E Eichelbaum M Brinkmann U Penger A Asante-Poku S Zanger UM | 2001 | Lancet2001，358，9279： | 1 |
| 3 | Antibodies against human cytochrome 17450 db 1 in autoimmlme hepatitis type 2显示文摘 | Zanger U M Hauri H P Loeper J | 1988 | Proc Nail Acad Sci USA1988，85，： | 1 |
| 4 | Patients with type Ⅱ autoimmune hepatitis express functionally intact cytochrome P450 dbl that is inhibited by LKM1 autoantibedies in vitro but not in vivo显示文摘 | Manns M Zanger U Gerken G | 1990 | Hepatology1990，12，： | 1 |
| 5 | Overlapping but distinct specificities of anti-liver-kidney microsomes antibodies in autoimmune hepatitis type Ⅱ and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes显示文摘 | Klein R Zanger U M Berg T etal | 1999 | Clin Exp Immunol1999，118，： | 1 |
| 6 | Expression of intestine drug-metabolizing enzymes in patients with chronic inflammatory bowel disease显示文摘 | Klotz U Hoensch H Schutz T Beaune P Zanger U Bode Johann C | 1998 | Curr Ther Res1998，59，8： | 1 |
| 7 | Cytochrome P450 enzymes in drug me- tabolism: regulation of gene expression, enzyme activities, and impact of genetic variation 显示文摘 | Zanger U M Schwab M | 2013 | Pharcol Ther2013，138，1： | 1 |
| 8 | A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver rnicrosomes显示文摘 | Turpeinen M Hofmann U Klein K Murdter T Schwab M Zanger UM | 2009 | Drug Metab Dispos2009，37，5： | 1 |
| 9 | Highthroughtput genotyping of thiopurine S-methyltransferase by denaturing HPLC 显示文摘 | Schaeffeler E Lang T Zanger U M | 2001 | Clin Chem2001，47，3： | 1 |
| 10 | Cytochrome P450 enzymes in drug metabolism:regulation of gene expression,enzyme activities,and impact of genetic variation显示文摘 | Zanger U M Schwab M | 2013 | Pharmcol Ther2013，138，1： | 1 |
| 11 | Highlymultiplexed genotyping of thiopurine s-methyltransferasevariants using MALD-TOF mass spectrometry:reliablegenotyping in different ethnic groups显示文摘 | Schaeffeler E Zanger U M Eichelbaum M | 2008 | Clin Chem2008，54，10： | 1 |
| 12 | Functional Pharmacogenetics/Genomics of Human Cytochromes P450 Involved in Drug Biotransformation 显示文摘 | ZANGER U M TURPEINEN M KLEIN K | 2008 | Analytical and Bioanalytical Chemistry2008，392，6： | 1 |
| 13 | Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population 显示文摘 | Griese EU Zanger UM Brudermanns U | 1998 | Pharmaco-genetics1998，8，： | 1 |
| 14 | Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus 显示文摘 | KAMDEM L K STREIT F ZANGER U M | 2005 | Clin Chem2005，51，8： | 1 |
| 15 | High-throughput genotyping of thiopurine Smethyl-transferase by denaturing HPLC 显示文摘 | SCHAEFFELER E LANG T ZANGER U M | 2001 | Clia Chem2001，47，3： | 1 |
| 16 | Disruption of myoglobin in mice induces multiple compensatory mechanisms 显示文摘 | Godecke A Flogel U Zanger K | 1999 | Proc Natl Acasd Sci USA1999，96，10： | 1 |
| 17 | Cytochrome P450 2D6:o- verview and update on pharmacology, genetics, biochemistry 显示文摘 | Zanger U M Raimundo S Eichelbaum M | 2004 | Naunyn Schmiedebergs Arch Pharmacol2004，369，1： | 1 |
| 18 | Contribution of CYPSA5 to the in vitro hepatic clearance of tacrolimus 显示文摘 | KAMDEM L K STREIT F ZANGER U M | 2005 | Clini Chem2005，51，8： | 1 |
| 19 | Cytochrome 17450 2D6 : Overview and update on pharmacology, genetics, bio- chemistry显示文摘 | ZANGER U M RAIMUNDO S EICHELBAUM M | 2004 | Naunyn Schmiedebergs Arch Pharmacol2004，369，1： | 1 |
| 20 | Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation 显示文摘 | ZANGER U M SCHWAB M | 2013 | Pharmacol Ther2013，138，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员